VSTM
VSTM
NASDAQ · Biotechnology

Verastem Inc

$8.54
+0.55 (+6.88%)
As of Sep 22, 2:55 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +64.5% upside
Low Target $11.84
Average Target $14.05
High Target $17.49
Current Price $8.54
Current
$8.54
Target
$14.05
$11.84 $14.05 avg $17.49
Scenario Analysis
Bear Case
$11.84
38.6%
Low target
Base Case
$14.05
+64.5%
Avg target
Bull Case
$17.49
+104.8%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$10.82
-21.1% from high
52-Week Low
$3.43
+149.0% from low
Target vs 52W High
$14.05
+29.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%